HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.

HighLife plans to prioritise procedural consistency and imaging-guided follow-up for safety in early commercial settings.

To determine the best path forward, you need to work with a cardiologist. They will review the tests you had and can ...

Mitral annular calcification (MAC) is a progressive, degenerative process increasingly recognised for its clinical impact.

It involves less pain, less bleeding, and there’s lower risk of infection,” said cardiothoracic surgeon Dr. Sanjay Tripathi.

Vibhu Parcha, M.D., a clinical research fellow in the UAB Division of Cardiovascular Disease, says this study was an extensive surveillance exercise at a national level to look into the implications ...

Korean women who discontinued statins before pregnancy did not show increased maternal cardiovascular risk and in fact tended ...

Almost 20 years’ worth of follow-up in an international registry shows that patients with degenerative mitral regurgitation who underwent mitral valve (MV) repair had better survival, fewer ...

How to navigate the likelihood ratios for mitral regurgitation presented by the physical exam, particularly auscultation, are the focus of this episode of AP Cardiology with host Andrew Perry, MD, ...

DALLAS, TX — The American College of Cardiology (ACC) has released an expert consensus decision pathway document on the management of mitral regurgitation (MR) [1]. Specifically, he said the document ...

The approval broadens Vetmedin’s label, which already covers management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.